Since doxorubicin (DOX) is known to cause DNA damage, we first examined the effects of doxorubicin on phosphorylation of H2AX (Ser139), a key DNA damage signal, in human breast cancer cells, MDA-MB-231 and MCF-7. The gene discussed is H2AX; the disease is breast cancer.